Michiana Hematology Oncology has elected Robin Zon president. She succeeds Rafat Ansar. Zon is only the third physician to be named president in the company’s history.
Zon graduated with a B.S. in Chemistry from the University of Detroit and worked in industry prior to earning her medical degree from Indiana University School of Medicine. She completed a medical oncology fellowship at Indiana University Cancer Center. Since joining Michiana Hematology Oncology, Zon has served as oncology director at Elkhart Hospital, director of oncology research at Memorial Hospital in South Bend and principal investigator for the only NCI granted Community Oncology Research group in Indiana.
She is a member of the American Society of Clinical Oncology, and awarded Fellow status, where she served on the board of directors, and chaired several committees, including the Clinical Practice Committee, and the Government Relations Committee. On this committee, she frequently travels to Washington, D.C. to meet with Congressional Staff and regulatory agencies to promote legislation and funding that benefits all cancer patients and their providers. In 2017, Zon received the Advocate of the Year Award, and in 2018 Advocacy awards from ASCO for her significant work on behalf of patients and their cancer care teams.